Lifestance Health Group Inc
NASDAQ:LFST
Intrinsic Value
Lifestance Health Group, Inc. operates a holding company. [ Read More ]
The intrinsic value of one
LFST
stock under the Base Case scenario is
12.46
USD.
Compared to the current market price of 5.71 USD,
Lifestance Health Group Inc
is
Undervalued by 54%.
Lifestance Health Group Inc's market capitalization is 2.2B USD.
LFST stock price is 5.71 USD.
LFST stock price (5.71 USD) is 54% less than its Intrinsic Value (12.46 USD).
LFST. Open DCF Valuation
LFST stock price (5.71 USD) is 54% less than its Relative Value (12.46 USD). Open Relative Valuation
LFST has upside potential of 57% compared to the average analyst price target.
Open Wall St Estimates
LFST's short-term assets (226m USD) exceed its short-term liabilties (203m USD).
LFST's Revenue has grown by an exceptional 23% over the past 12 months.
LFST's Altman Z-Score is equal to 2.28.
LFST's ROIC (Return on Invested Capital) has decreased in the last 3 years from 1% to -8%.
LFST's Revenue is forecast to grow at a rate of 14% per year over the next 3 years.
LFST's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -8%.
LFST's ROE (Return on Equity) has significantly increased in the last 3 years from -35% to -13%, and is approaching profitability.
LFST's ROE (Return on Equity) for the past 12 months is negative and is equal to -13%.
LFST has negative Operating Income for the last twelve months.
LFST has negative Net Income for the last twelve months.
LFST has positive Net Debt. This means that the company has more debt (280m USD) than cash and short-term investments (79m USD).
LFST's Revenue has been growing by an exceptional 41% per year for the last 3 years.
LFST has negative Free Cash Flow for the last twelve months.
LFST has negative three-year average ROIC (Return on Invested Capital): -9%. The company is not efficient at using invested capital to generate operating income.
LFST's long-term assets (2B USD) exceed its long-term liabilties (681m USD).
LFST's D/E (Debt to Equity) is very low and is equal to 0.2.
LFST has negative three-year average ROE (Return on Equity): -16%. The company is not efficient at transforming stockholders' equity into net income.
LFST doesn't generate enough operating income (-187m USD) to safely cover interest payments on its debt (21m USD).
Valuation Backtest
Lifestance Health Group Inc
Run backtest to discover the historical profit from buying and selling
LFST
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Lifestance Health Group Inc
Balance Sheet Decomposition
Lifestance Health Group Inc
| Current Assets | 225.7m |
| Cash & Short-Term Investments | 78.8m |
| Receivables | 125.4m |
| Other Current Assets | 21.5m |
| Non-Current Assets | 1.9B |
| PP&E | 358.9m |
| Intangibles | 1.5B |
| Other Non-Current Assets | 10.9m |
| Current Liabilities | 202.9m |
| Accounts Payable | 7.1m |
| Accrued Liabilities | 184m |
| Other Current Liabilities | 11.9m |
| Non-Current Liabilities | 478.2m |
| Long-Term Debt | 280.3m |
| Other Non-Current Liabilities | 197.9m |
Earnings Waterfall
Lifestance Health Group Inc
|
Revenue
|
1.1B
USD
|
|
Operating Expenses
|
-1.2B
USD
|
|
Operating Income
|
-187.3m
USD
|
|
Other Expenses
|
1.1m
USD
|
|
Net Income
|
-186.3m
USD
|
Free Cash Flow Analysis
Lifestance Health Group Inc
What is Free Cash Flow?
LFST Profitability Score
Profitability Due Diligence
Lifestance Health Group Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Lifestance Health Group Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
LFST Solvency Score
Solvency Due Diligence
Lifestance Health Group Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Lifestance Health Group Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LFST Price Targets Summary
Lifestance Health Group Inc
According to Wall Street analysts, the average 1-year price target for
LFST
is 8.96 USD
with a low forecast of 8.08 USD and a high forecast of 10.5 USD.
Ownership
LFST Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
LFST Price
Lifestance Health Group Inc
| Average Annual Return | -53.92% |
| Standard Deviation of Annual Returns | 0.59% |
| Max Drawdown | -85% |
| Market Capitalization | 2.2B USD |
| Shares Outstanding | 380 690 000 |
| Percentage of Shares Shorted | 25.91% |
Company Profile
Lifestance Health Group Inc
Country
Industry
Market Cap
Dividend Yield
Description
Lifestance Health Group, Inc. operates a holding company. The company is headquartered in Scottsdale, Arizona and currently employs 6,635 full-time employees. The company went IPO on 2021-06-10. The firm is focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering. The firm's clinicians offer patients a range of mental health services, including psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to improve patient access and treatment. The company treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. The company operates approximately 534 centers and employs over 4,800 clinicians across the United States.
Contact
IPO
Employees
Officers
The intrinsic value of one
LFST
stock under the Base Case scenario is
12.46
USD.
Compared to the current market price of 5.71 USD,
Lifestance Health Group Inc
is
Undervalued by 54%.
You don't have any saved screeners yet
